Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armin Scheffler

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Scientia Pharmaceutica|May 28, 2011
Preparation of herbal tea as infusion or by maceration at room temperature using mistletoe tea as an exampleSebastian Jäger, Markus Beffert, Katharina Hoppe, et al.
The Journal of Headache and Pain|May 10, 2022
Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world studyHannah Schenk, Dagny Holle, Michael Nsaka, et al.
The Journal of Headache and Pain|September 21, 2021
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experienceArmin Scheffler, Hannah Schenk, Sebastian Wurthmann, et al.
Cephalalgia : an International Journal of Headache|June 16, 2020
Impaired wound healing in a migraine patient as a possible side effect of calcitonin gene-related peptide receptor antibody treatment: A case reportSebastian Wurthmann, Steffen Nägel, Eva Hadaschik, et al.
Brain and Behavior|June 10, 2022
Real-world evidence following a mandatory treatment break after a 1-year prophylactic treatment with calcitonin gene-related peptide (pathway) monoclonal antibodiesMichael Nsaka, Armin Scheffler, Sebastian Wurthmann, et al.
European Journal of Neurology|August 11, 2021
Response to the Letter to the Editor by Arshad and Bronstein "Motion perception in vestibular migraine"Sebastian Wurthmann, Steffen Naegel, Michael Nsaka, et al.
Plos One|April 25, 2013
Triterpenoids amplify anti-tumoral effects of mistletoe extracts on murine B16.f10 melanoma in vivoChristian M Strüh, Sebastian Jäger, Astrid Kersten, et al.
The Journal of Headache and Pain|July 5, 2020
Erenumab in highly therapy-refractory migraine patients: First German real-world evidenceArmin Scheffler, Olga Messel, Sebastian Wurthmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 24, 2008
Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot studyConstance Huyke, Juliane Reuter, Mirko Rödig, et al.
European Journal of Neurology|April 29, 2021
Sensitized rotatory motion perception and increased susceptibility to motion sickness in vestibular migraine: A cross-sectional studySebastian Wurthmann, Steffen Naegel, Miriam Roesner, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Scientia Pharmaceutica|May 28, 2011
Preparation of herbal tea as infusion or by maceration at room temperature using mistletoe tea as an exampleSebastian Jäger, Markus Beffert, Katharina Hoppe, et al.
The Journal of Headache and Pain|May 10, 2022
Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world studyHannah Schenk, Dagny Holle, Michael Nsaka, et al.
The Journal of Headache and Pain|September 21, 2021
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experienceArmin Scheffler, Hannah Schenk, Sebastian Wurthmann, et al.
Cephalalgia : an International Journal of Headache|June 16, 2020
Impaired wound healing in a migraine patient as a possible side effect of calcitonin gene-related peptide receptor antibody treatment: A case reportSebastian Wurthmann, Steffen Nägel, Eva Hadaschik, et al.
Brain and Behavior|June 10, 2022
Real-world evidence following a mandatory treatment break after a 1-year prophylactic treatment with calcitonin gene-related peptide (pathway) monoclonal antibodiesMichael Nsaka, Armin Scheffler, Sebastian Wurthmann, et al.
European Journal of Neurology|August 11, 2021
Response to the Letter to the Editor by Arshad and Bronstein "Motion perception in vestibular migraine"Sebastian Wurthmann, Steffen Naegel, Michael Nsaka, et al.
Plos One|April 25, 2013
Triterpenoids amplify anti-tumoral effects of mistletoe extracts on murine B16.f10 melanoma in vivoChristian M Strüh, Sebastian Jäger, Astrid Kersten, et al.
The Journal of Headache and Pain|July 5, 2020
Erenumab in highly therapy-refractory migraine patients: First German real-world evidenceArmin Scheffler, Olga Messel, Sebastian Wurthmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 24, 2008
Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot studyConstance Huyke, Juliane Reuter, Mirko Rödig, et al.
European Journal of Neurology|April 29, 2021
Sensitized rotatory motion perception and increased susceptibility to motion sickness in vestibular migraine: A cross-sectional studySebastian Wurthmann, Steffen Naegel, Miriam Roesner, et al.
Pageof 3